Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade.
Journal article
Kaur G. et al, (2022), Nat Commun, 13
Identification of early neurodegenerative pathways in progressive multiple sclerosis.
Journal article
Kaufmann M. et al, (2022), Nat Neurosci
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis.
Journal article
Kaufmann M. et al, (2021), Med (N Y), 2, 296 - 312.e8
Structural and regulatory diversity shape HLA-C protein expression levels.
Journal article
Kaur G. et al, (2017), Nat Commun, 8
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity.
Journal article
Dendrou CA. et al, (2016), Sci Transl Med, 8
Natural killer cells and their receptors in multiple sclerosis.
Journal article
Kaur G. et al, (2013), Brain, 136, 2657 - 2676
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Journal article
Gregory AP. et al, (2012), Nature, 488, 508 - 511
Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.
Journal article
Kaur G. et al, (2010), Mol Immunol, 48, 321 - 332
The role of Foxp3 in regulatory T cell differentiation and function
Journal article
Kaur G. et al, (2009), Current Immunology Reviews, 5, 89 - 101
A role of cellular prion protein in programming T-cell cytokine responses in disease.
Journal article
Ingram RJ. et al, (2009), FASEB J, 23, 1672 - 1684
The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells.
Journal article
Isaacs JD. et al, (2008), Immunology, 125, 313 - 319
CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
Journal article
Duggleby RC. et al, (2007), Immunology, 121, 129 - 139